Gerencia de Atención Primaria, Albacete Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2008
NCT01452243
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Gerencia de Atención Primaria, Albacete

Active Ingredients

Drugs in Phase 3 Trials (2)

calcium (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (1)

plant stanol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fractures, Bone (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3